Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Nippon Shinyaku Co Ltd

+ Add to Watchlist

4516:JP

4,425.0 JPY 15.0 0.34%

As of 21:29:40 ET on 03/05/2015.

Snapshot for Nippon Shinyaku Co Ltd (4516)

Open: 4,410.0 Day's Range: 4,400.0 - 4,530.0 Volume: 180,000
Previous Close: 4,410.0 52wk Range: 1,734.0 - 4,530.0 1-Yr Rtn: +128.02%

Stock Chart for 4516

No chart data available.
  • 4516:JP 4,430.0
  • 1D
  • 1M
  • 1Y
4,410.0
Interactive 4516 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4516

Current P/E Ratio (ttm) 48.2800
Estimated P/E(03/2015) 48.4213
Relative P/E vs. TPX 2.7726
Earnings Per Share (JPY) (ttm) 91.8600
Est. EPS (JPY) (03/2015) 91.5920
Est. PEG Ratio -
Market Cap (M JPY) 311,565.33
Shares Outstanding (M) 70.25
30 Day Average Volume 227,467
Price/Book (mrq) 3.0763
Price/Sale (ttm) 3.7660
Dividend Indicated Gross Yield 0.56%
Cash Dividend (JPY) 13.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 5.92%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4516

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4516

Nippon Shinyaku Co., Ltd. manufactures pharmaceutical and health foods products. The Company produces drugs for urinary, nerve, respiratory, and circulatory systems as well as analgesic and anti-inflammatory drugs. Nippon Shinyaku also develops synthetic anti-bacterial agents.

Shigenobu MaekawaPresidentTsugio TanakaManaging Director
Hiroshi AdachiDirectorYoshiro YuraDirector
More Company Profile & Key Executives for 4516

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil